EyePoint Pharmaceuticals, Inc. (EYPT)
NASDAQ: EYPT · Real-Time Price · USD
10.70
-0.31 (-2.82%)
Aug 14, 2025, 12:05 PM - Market open
EyePoint Pharmaceuticals Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$24.88
Upside
+132.52%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $27 | Strong Buy | Maintains | $27 | +152.34% | Aug 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $22 → $23 | Strong Buy | Maintains | $22 → $23 | +114.95% | Aug 6, 2025 |
| RBC Capital | RBC Capital | Buy Initiates $28 | Buy | Initiates | $28 | +161.68% | Jun 17, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +105.61% | May 29, 2025 |
| Mizuho | Mizuho | Buy Maintains $30 → $26 | Buy | Maintains | $30 → $26 | +142.99% | May 16, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $33 → $27 | Strong Buy | Maintains | $33 → $27 | +152.34% | May 8, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +208.41% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +105.61% | Mar 6, 2025 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $33 | Strong Buy | Maintains | $33 | +208.41% | Feb 6, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $33 | Strong Buy | Initiates | $33 | +208.41% | Jan 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +105.61% | Dec 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $22 | Strong Buy | Maintains | $30 → $22 | +105.61% | Nov 11, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 → $33 | Strong Buy | Maintains | $28 → $33 | +208.41% | Nov 8, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $28 | Strong Buy | Maintains | $28 | +161.68% | Oct 29, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +180.37% | Oct 25, 2024 |
| Scotiabank | Scotiabank | Buy Initiates $18 | Buy | Initiates | $18 | +68.22% | Oct 16, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.